Inhibition of corneal neovascularization by α(v)-integrin antagonists in the rat

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 238, Issue 1, 2000, Pages 88-93

  Klotz, Oliver ^b   Park, Joon Keun ^a   Pleyer, Uwe ^b   Hartmann, Christian ^b   Baatz, Holger ^b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN ANTAGONIST; FIBROBLAST GROWTH FACTOR; INTEGRIN; MONOCLONAL ANTIBODY LM 609; OFLOXACIN; PENTOBARBITAL; RECEPTOR BLOCKING AGENT; SILVER NITRATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG IMPLANT; FEMALE; IMAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034019669     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050015     Document Type: Article

References (21)

1. Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571
2. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu TH, Klier G, et al. (1994) Integrin alpha(v)beta(3) antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164
3. Buck CA, Horwitz AF (1987) Cell surface receptors for extracellular matrix molecules. Annu Rev Cell 13:179-205
4. Enenstein J, Kramer RH (1994) Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin. J Invest Dermatol 103:381-386
5. v integrins. Science 270:1500-1502
6. 5 in ocular neovascular diseases. Proc Natl Acad Sci USA 93:9764-9769
7. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529-533
8. Hynes RO (1987) Integrins a family of cell surface receptors. Cell 48:549-554
9. Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11-25
10. Kenyon BM, Voest EE, Chen CC. Flynn E, Folkman J, D'Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37:1625-1632
11. Klintworth GK (1989) Corneal Angiogenesis. A comprehensive and critical review. Springer, Berlin Heidelberg New York
12. Langer R, Folkmann J (1976) Polymers for the sustained relase of proteins and other macromolecules. Nature 263:797-800
13. Lauweryns B, van den Oord JJ, Misotten L (1992) Localization of the cytoadhesin integrins in the human cornea. Graefe's Arch Clin Exp Ophthalmol 230:264-268
14. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA (1993) Integrin beta 1-and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121:163-170
15. 3 inhibit retinal neovascularization in a murine model. Lab Invest 75:563-573
16. Mitjans F, Sander D, Adan J, Sutter A, Martinez JM, Jaggle CS, Moyano JM, Kreysch HG, Piulats J, Goodman SL (1995) An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of human melanoma in nude mice. J Cell Sci 108:2825-2838
17. Pfaff M, Tangemann K, Muller B, Gurrath M, Muller G, Kessler H, et al. (1994) Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta1 integrins. J Biol Chem 269:20233-20238
18. Polverini PJ (1995) The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6:230-247
19. Proia AD, Chandler DB, Haynes WL, Smith CF, Suvarnamani C, Erkel FH, et al. (1988) Quantitation of corneal neovascularization using computerized image analysis. Lab Invest 58:473-479
20. Ruosolahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and Integrins. Science 238:491-497
21. Smith JW, Cheresh DA (1990) Integrin (alpha v beta 3) - ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor. J Biol Chem 265:2168-2172